Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
Top Cited Papers
- 13 January 2015
- journal article
- position statement
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 58 (3), 429-442
- https://doi.org/10.1007/s00125-014-3460-0
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exerciseDiabetes, Obesity and Metabolism, 2013
- Combination therapy with GLP‐1 receptor agonists and basal insulin: a systematic review of the literatureDiabetes, Obesity and Metabolism, 2012
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugsDiabetologia, 2012
- Alogliptin as a third oral antidiabetic drug in patients with type 2 diabetes and inadequate glycaemic control on metformin and pioglitazone: a 52-week, randomized, double-blind, active-controlled, parallel-group studyDiabetes, Obesity and Metabolism, 2011
- Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With MetforminDiabetes Care, 2011
- Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetesDiabetes, Obesity and Metabolism, 2011
- Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular OutcomesDiabetes Care, 2010
- U-500 Regular InsulinDiabetes Care, 2009
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Effects of Intensive Glucose Lowering in Type 2 DiabetesThe New England Journal of Medicine, 2008